Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study
NCT02472080
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
OTHER
Sponsor class
Stopped
inefficiency
Conditions
Thyroid Cancer
Interventions
DRUG:
gemcitabine -oxaliplatine combination
Sponsor
Assistance Publique - Hôpitaux de Paris